Piramal Pharma
Manufacturing · India · 11-50 Employees
View Company Info for Free
Overview
Headquarters
plot k -1 Additional Midc Mahad Raigad, ...Phone Number
(859) 977-8600Website
www.piramalpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Piramal Pharma
Piramal Pharma Limited (PPL) is a global provider of Contract Development and Manufacturing Organization (CDMO) services, complex hospital generics, and consumer healthcare products, operating in over 100 countries with 17 manufacturing facilities. The company offers end-to-end development and manufacturing solutions through its Piramal Pharma Solutions division, serving clients across North America, Europe, and Asia. In the critical care sector, Piramal Critical Care specializes in inhaled anesthetics hospital generics, while Piramal Consumer Healthcare focuses on self-care products in the Indian market with established brands. PPL is committed to delivering science-driven, quality-focused, and patient-centric solutions to its diverse clientele.Explore more
Piramal Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Piramal Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Piramal Pharma launches new products
Check out if Piramal Pharma is spiking on competitors!
Click to see if Piramal Pharma had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Piramal Pharma
Check if Piramal Pharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Piramal Pharma recently announced quarterly report
Piramal Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Piramal Pharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Piramal Pharma as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Piramal Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Piramal Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Piramal Pharma.
Piramal Pharma Tech Stack
A closer look at the technologies used by Piramal Pharma
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Piramal Pharma News & Media
Piramal Pharma likely to hit fresh highs as CDMO recovery lifts EBITDA, says Quest CIO
Piramal Pharma Ltd could be setting up for a sharper earnings rebound after a difficult year, with Quest Investment Managers betting that a recovery in its contract development and manufacturing operations (CDMO) will help the stock move back toward its earlier peaks. The investment case, according to Quest CIO and portfolio manager Rakesh Vyas, rests on a fading destocking drag, a healthier growth trajectory in the core CDMO business and the potential for operating leveragePiramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations
Lowest-ever Scope 1 and Scope 2 emissions mark a milestone year in the Company's SBTi-approved decarbonisation journey MUMBAI, India, Aug. 26, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals company, today released its Sustainability Report 2025–26, showcasing significant progress across its environmental, social and governance (ESG) priorities. Anchored by the theme "Advancing Innovation, Leveraging Sustainability," the report highligPiramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations
Lowest-ever Scope 1 and Scope 2 emissions mark a milestone year in the Company's SBTi-approved decarbonisation journey MUMBAI, India, Aug. 26, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals company, today released its...Piramal Pharma Strengthens Future Ready Operations with 22.6% Emissions Reduction, 41% Renewable Energy and Zero USFDA OAI Observations
Lowest-ever Scope 1 and Scope 2 emissions mark a milestone year in the Company's SBTi-approved decarbonisation journey Mumbai, India, Aug. 26, 2026 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals company, today released its...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Piramal Pharma
Sign Up For FreeTo access detailed company insights
Piramal Pharma Limited (PPL) is a global provider of Contract Development and Manufacturing Organization (CDMO) services, complex hospital generics, and consumer healthcare products, operating in over 100 countries with 17 manufacturing facilities. The company offers end-to-end development and manufacturing solutions through its Piramal Pharma Solu... Read More
